Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of America Corp (BAC) vs Zoetis Inc (ZTS) Price & Performance

Bank of America CorpTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Bank of America Corp vs Zoetis Inc — how do they compare? Bank of America Corp trades at $61.73 (market cap $425.43B), while Zoetis Inc trades at $76.04 (market cap $31.05B). The key difference: Bank of America Corp is far larger — about 13.7× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.86%). Which is the better fit depends on your goals.

BACZTS
Market Cap
$425.43B$31.05B
Volume
55,637,172
Sector
FinancialsHealth
52-Week High
$60.62$156.76
52-Week Low
$44.92$71.91
Dividend Yield
1.85%2.86%
Enterprise Value
$38.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of America Corp

Bank of America (BAC) trades at $59.50, down 0.28% today, with a bullish technical outlook and strong fundamental support. The stock shows consistent earnings beats, with Q2 2026 EPS of $1.21 exceeding the $1.13 estimate. Revenue growth accelerated to $113.1 billion in 2025, and the P/E ratio of 14 remains attractive. Recent news highlights strategic partnerships and hiring initiatives, reinforcing long-term growth prospects.

BAC presents a favorable investment case with solid profitability, a 64.8% analyst buy rating, and a consensus price target of $63.79 offering 7.2% upside. Risks include sensitivity to interest rates and macroeconomic volatility, but the bank's deposit franchise and capital flexibility provide resilience. The stock is well-positioned for steady appreciation amid supportive technicals and fundamental strength.

Zoetis Inc

Zoetis (ZTS) trades at $75.39, down 0.22% with bearish technical signals and mixed sentiment. The company maintains strong fundamentals with $9.47B revenue, 28.03% net margin, and robust profitability metrics (ROE 67.75%, ROA 18.27%). Recent Q1 2026 earnings missed expectations, while multiple law firms have filed class action lawsuits alleging securities violations between January 2025 and May 2026.

Despite strong financials and analyst consensus price target of $101.43 (34.5% upside), ZTS faces significant legal risks and technical weakness. The stock presents a value opportunity for long-term investors willing to navigate near-term volatility, though the class action lawsuits create substantial uncertainty for shareholder value.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of America Corp

Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.

Read more on BAC

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS